AbstractBackgroundThere is controversy about risk of malignant arrhythmias and stroke in patients with apical aneurysms in hypertrophic cardiomyopathy (HCM).ObjectivesThe aim of this study was to e…
A new National Cancer Institute (NCI) initiative seeks to redefine the standard for personalized cancer care in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).…
Abstract. High-risk multiple myeloma (MM) is genomically unstable, comprised of heterogeneous populations of tumor cells that evolve over time. Light chain escape (LCE) is a…
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
People diagnosed with metastatic breast cancer have a notably increased risk of developing heart disease.
JACC: Case Reports is inviting submissions of challenging rheumatic heart disease (RHD) cases highlighting the global burden of cardiovascular disease for a forthcoming special issue…
This cross-sectional study evaluates contemporary patterns of lipoprotein a testing among US veterans receiving care through the Veterans Health Administration.
Theresa Wicklin Gillespie, PhD, MA, RN, FAAN, discusses her JADPRO Live workshop on how advanced practice providers can improve clinical trial representation and access.
AbstractUndifferentiated cardiac tumors represent a diagnostic dilemma that requires meticulous workup. We present the case of a 67-year-old woman with a right atrial mass that…
Heart failure with preserved ejection fraction (HFpEF) makes up ∼ 50% of HF cases of HF, and it shows increasing prevalence.1 HFpEF is characterized by…
AbstractBackgroundPrevious research has suggested that time-in-target range (TTR) for systolic blood pressure (SBP) was associated with adverse cardiovascular events, but real-world data studies re…
